ArticleCureus2025
Liver Subcapsular Hematoma Conservative Treatment in HELLP (Hemolysis, Elevated Liver Enzymes, and Low Platelet Count) Syndrome: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subcapsular hepatic hematoma is a life-threatening complication during pregnancy. Conservative treatment could be possible with an equipped unit and a fully staffed team available 24 hours a day. We present the case of a 40-year-old patient at 37 weeks of gestation with preeclampsia meeting severe features who presented with diffuse abdominal pain radiating to the right shoulder. In a private hospital, during a cesarean section, hepatic bleeding was observed. In our hospital, partial HELLP (Hemolysis, Elevated liver enzymes, and Low Platelet count) syndrome was diagnosed, and treatment began. Once stabilized, a CT scan revealed two subcapsular hepatic hematomas with a total volume of 1700 cc. The multidisciplinary team adopted a conservative management approach, incorporating close clinical and biochemical follow-up. After 25 days, the patient was discharged home with a significant reduction in the size of both hematomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.